1808667 |
Testicular Safety of Filgotinib in Males with Ulcerative Colitis |
30/06/2020 |
1807660 |
M16-006 |
29/05/2020 |
1807659 |
M16-000 |
27/01/2023 |
1807651 |
GS-US-419-4015 Filgotinib in treatment of Small Bowel Crohn’s Disease |
22/07/2019 |
1804577 |
PREdiCCt |
31/05/2020 |
1804569 |
Predictors of depression in people with Ulcerative Colitis – Version 1 |
01/11/2019 |
1802586 |
Biomarkers of malignancy from pancreatic cysts |
03/03/2019 |
1802576 |
MRI for early response prediction to anti-TNF therapy |
01/05/2019 |
1712550 |
PROFILE – personalised medicine in Crohn’s disease |
28/02/2020 |
1711527 |
GS-US-419 4016 Filgotinib in treatment of Perianal Fistulizing Crohns |
23/08/2019 |
1708486 |
Long Term Safety of Filgotinib in Active Crohn’s Disease |
28/02/2023 |
1708483 |
M14-234 |
01/05/2022 |
1708482 |
M14-533 Ph 3 study in Mod/Severe Ulcerative Colitis Extension study |
30/05/2022 |
1707456 |
Efficacy and Safety of Fligotinib in Active Crohn’s Disease |
31/12/2019 |
1703395 |
GAST 5721 |
30/11/2020 |
1612343 |
GAST 5634 |
31/03/2019 |
1609308 |
GAST 5439 |
14/08/2019 |
1609307 |
GAST 5440 |
30/06/2021 |
1609302 |
I-CARE – IBD Cancer and Serious Infections in Europe |
31/12/2018 |
1607279 |
SPARE |
31/03/2021 |
1607270 |
GAST 4844 |
30/09/2021 |
1511175 |
GAST 4684 |
13/03/2024 |
1511174 |
GAST 4652 |
30/06/2019 |
1511170 |
GAST 3773 |
13/03/2024 |
1508131 |
GAST 3772 |
09/05/2021 |
1504079 |
GAST 3559 (Ulcerative Colitis) |
28/02/2019 |
1307805 |
PANTS |
02/06/2019 |
1206654 |
PRED 4 – Predicting Serious Drug Side Effects in Gastroenterology |
31/12/2019 |
1008424 |
BOSS |
14/10/2021 |
906278 |
IBD-GEN |
10/11/2018 |